GSE126999 ARVCF knockdown 1 v 2 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE126999_ARVCF knockdown_1_v_2_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE126999_ARVCF knockdown_1_v_2_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE126999_ARVCF knockdown_1_v_2_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE126999_ARVCF knockdown_1_v_2_human_up.

Results found

Linked to

 

Label

Description

 

Gene

double homeobox A pseudogene 8

Gene

TP53 target 1

Gene

CDH13 antisense RNA 2

Gene

long intergenic non-protein coding RNA, p53 induced transcript

Gene

pleckstrin homology and RUN domain containing M1 pseudogene 1

Gene

LBX2 antisense RNA 1

Gene

surfactant associated 1, lncRNA

Gene

UNC5B antisense RNA 1

Gene

long intergenic non-protein coding RNA 1410

Gene

uncharacterized LOC124905143

  • Gene

    double homeobox A pseudogene 8



  • Gene

    CDH13 antisense RNA 2


  • Gene

    long intergenic non-protein coding RNA, p53 induced transcript


  • Gene

    pleckstrin homology and RUN domain containing M1 pseudogene 1


  • Gene

    LBX2 antisense RNA 1


  • Gene

    surfactant associated 1, lncRNA


  • Gene

    UNC5B antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 1410


  • Gene

    uncharacterized LOC124905143

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.